AZTA
Price
$30.54
Change
+$0.62 (+2.07%)
Updated
Aug 29 closing price
Capitalization
1.4B
80 days until earnings call
BAX
Price
$24.69
Change
+$0.29 (+1.19%)
Updated
Aug 29 closing price
Capitalization
12.68B
61 days until earnings call
Interact to see
Advertisement

AZTA vs BAX

Header iconAZTA vs BAX Comparison
Open Charts AZTA vs BAXBanner chart's image
Azenta
Price$30.54
Change+$0.62 (+2.07%)
Volume$437.38K
Capitalization1.4B
Baxter International
Price$24.69
Change+$0.29 (+1.19%)
Volume$4.05M
Capitalization12.68B
AZTA vs BAX Comparison Chart in %
Loading...
AZTA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
BAX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
AZTA vs. BAX commentary
Aug 31, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is AZTA is a StrongBuy and BAX is a StrongBuy.

Interact to see
Advertisement
COMPARISON
Comparison
Aug 31, 2025
Stock price -- (AZTA: $30.54 vs. BAX: $24.69)
Brand notoriety: AZTA and BAX are both not notable
Both companies represent the Pharmaceuticals: Other industry
Current volume relative to the 65-day Moving Average: AZTA: 54% vs. BAX: 56%
Market capitalization -- AZTA: $1.4B vs. BAX: $12.53B
AZTA [@Pharmaceuticals: Other] is valued at $1.4B. BAX’s [@Pharmaceuticals: Other] market capitalization is $12.53B. The market cap for tickers in the [@Pharmaceuticals: Other] industry ranges from $169.67B to $0. The average market capitalization across the [@Pharmaceuticals: Other] industry is $10.97B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

AZTA’s FA Score shows that 0 FA rating(s) are green whileBAX’s FA Score has 2 green FA rating(s).

  • AZTA’s FA Score: 0 green, 5 red.
  • BAX’s FA Score: 2 green, 3 red.
According to our system of comparison, BAX is a better buy in the long-term than AZTA.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

AZTA’s TA Score shows that 7 TA indicator(s) are bullish while BAX’s TA Score has 5 bullish TA indicator(s).

  • AZTA’s TA Score: 7 bullish, 3 bearish.
  • BAX’s TA Score: 5 bullish, 3 bearish.
According to our system of comparison, AZTA is a better buy in the short-term than BAX.

Price Growth

AZTA (@Pharmaceuticals: Other) experienced а -3.20% price change this week, while BAX (@Pharmaceuticals: Other) price change was +1.32% for the same time period.

The average weekly price growth across all stocks in the @Pharmaceuticals: Other industry was +0.93%. For the same industry, the average monthly price growth was +6.00%, and the average quarterly price growth was +26.47%.

Reported Earning Dates

AZTA is expected to report earnings on Nov 18, 2025.

BAX is expected to report earnings on Oct 30, 2025.

Industries' Descriptions

@Pharmaceuticals: Other (+0.93% weekly)

Pharmaceuticals (Other) comprise companies that are involved in the discovery, development or manufacturing of therapeutic and preventative medicines. They often collaborate with or acquire other pharmaceutical/healthcare firms. Examples of companies in this segment include Bausch Health Companies Inc., Icon Plc and Perrigo Company Plc.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
BAX($12.7B) has a higher market cap than AZTA($1.4B). BAX YTD gains are higher at: -13.843 vs. AZTA (-38.920). BAX has higher annual earnings (EBITDA): 1.04B vs. AZTA (11.3M). BAX has more cash in the bank: 1.8B vs. AZTA (319M). AZTA has less debt than BAX: AZTA (52.6M) vs BAX (10.3B). BAX has higher revenues than AZTA: BAX (10.9B) vs AZTA (669M).
AZTABAXAZTA / BAX
Capitalization1.4B12.7B11%
EBITDA11.3M1.04B1%
Gain YTD-38.920-13.843281%
P/E RatioN/A87.85-
Revenue669M10.9B6%
Total Cash319M1.8B18%
Total Debt52.6M10.3B1%
FUNDAMENTALS RATINGS
AZTA vs BAX: Fundamental Ratings
AZTA
BAX
OUTLOOK RATING
1..100
6012
VALUATION
overvalued / fair valued / undervalued
1..100
70
Overvalued
20
Undervalued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
9492
PRICE GROWTH RATING
1..100
6465
P/E GROWTH RATING
1..100
5331
SEASONALITY SCORE
1..100
8550

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

BAX's Valuation (20) in the Medical Specialties industry is somewhat better than the same rating for AZTA (70) in the Electronic Production Equipment industry. This means that BAX’s stock grew somewhat faster than AZTA’s over the last 12 months.

BAX's Profit vs Risk Rating (100) in the Medical Specialties industry is in the same range as AZTA (100) in the Electronic Production Equipment industry. This means that BAX’s stock grew similarly to AZTA’s over the last 12 months.

BAX's SMR Rating (92) in the Medical Specialties industry is in the same range as AZTA (94) in the Electronic Production Equipment industry. This means that BAX’s stock grew similarly to AZTA’s over the last 12 months.

AZTA's Price Growth Rating (64) in the Electronic Production Equipment industry is in the same range as BAX (65) in the Medical Specialties industry. This means that AZTA’s stock grew similarly to BAX’s over the last 12 months.

BAX's P/E Growth Rating (31) in the Medical Specialties industry is in the same range as AZTA (53) in the Electronic Production Equipment industry. This means that BAX’s stock grew similarly to AZTA’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
AZTABAX
RSI
ODDS (%)
Bullish Trend 2 days ago
77%
Bullish Trend 2 days ago
63%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
69%
Bearish Trend 2 days ago
65%
Momentum
ODDS (%)
Bullish Trend 2 days ago
72%
Bullish Trend 2 days ago
53%
MACD
ODDS (%)
Bullish Trend 2 days ago
72%
Bullish Trend 2 days ago
60%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
80%
Bullish Trend 2 days ago
54%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
83%
Bearish Trend 2 days ago
64%
Advances
ODDS (%)
Bullish Trend 9 days ago
71%
Bullish Trend 6 days ago
51%
Declines
ODDS (%)
Bearish Trend 3 days ago
84%
Bearish Trend 10 days ago
61%
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
74%
Bullish Trend 2 days ago
59%
Aroon
ODDS (%)
Bullish Trend 2 days ago
76%
Bearish Trend 2 days ago
57%
View a ticker or compare two or three
Interact to see
Advertisement
AZTA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
BAX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
TEGRX30.10N/A
N/A
Templeton Growth R
RYCIX151.12N/A
N/A
Rydex Consumer Products Inv
PCGRX25.29N/A
N/A
Victory Pioneer Mid Cap Value A
NRMGX19.68N/A
N/A
Neuberger Berman Mid Cap Growth R6
GGESX25.96N/A
N/A
Nationwide Global Sust Eq Instl Svc

AZTA and

Correlation & Price change

A.I.dvisor indicates that over the last year, AZTA has been loosely correlated with IQV. These tickers have moved in lockstep 60% of the time. This A.I.-generated data suggests there is some statistical probability that if AZTA jumps, then IQV could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To AZTA
1D Price
Change %
AZTA100%
+2.07%
IQV - AZTA
60%
Loosely correlated
+1.10%
RVTY - AZTA
59%
Loosely correlated
+0.99%
A - AZTA
59%
Loosely correlated
+0.56%
MTD - AZTA
59%
Loosely correlated
+1.40%
BRKR - AZTA
58%
Loosely correlated
+1.55%
More

BAX and

Correlation & Price change

A.I.dvisor indicates that over the last year, BAX has been closely correlated with ALGN. These tickers have moved in lockstep 68% of the time. This A.I.-generated data suggests there is a high statistical probability that if BAX jumps, then ALGN could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To BAX
1D Price
Change %
BAX100%
+1.90%
ALGN - BAX
68%
Closely correlated
+0.59%
LUNG - BAX
53%
Loosely correlated
-2.84%
STE - BAX
51%
Loosely correlated
+0.12%
SYK - BAX
51%
Loosely correlated
+0.45%
SOLV - BAX
50%
Loosely correlated
+0.59%
More